Vimarsana
Biggest News Aggregation in the World

Dose Response Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Dose Response Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Dose Response Study Today - Breaking & Trending Today

Studies support paraxanthine's cognitive and hunger-reducing effects - Vimarsana News

Studies support paraxanthine's cognitive and hunger-reducing effects

Published: May 29, 2024

The science supporting the potential health benefits of the caffeine metabolite paraxanthine continues to grow with a new study showing it outperforms caffeine for mental stamina and accuracy before and after exercise.

Source: nutraingredients-usa.com
Related Topics:
United StatesLashawn WellsNutraingredients United StatesSupplyside WestInternational SocietySports NutritionIngenious IngredientsDietary SupplementsDose Response StudyExamine ParaxanthineEnergy Expenditure
JERAYGO (aprocitentan) recommended for approval in Europe for the treatment of resistant hypertension - Vimarsana News

JERAYGO (aprocitentan) recommended for approval in Europe for the treatment of resistant hypertension

Published: April 26, 2024

Ad hoc announcement pursuant to Art. 53 LR Idorsia receives a positive opinion from the Committee for Medicinal Products for Human Use for JERAYGO™ as the first and only endothelin receptor...

Source: marketscreener.com
Related Topics:
Switzerland GeneralUnited StatesJean Paul ClozelClozelm AprocitentanJ Physiol PharmacolAndrewc WeissEuropean Medicines AgencyEuropean CommissionEuropean UnionCommittee For Medicinal Products Human UseSwiss ExchangeDrug AdministrationEuropean Union Member StatesIdorsia LtdIdorsia Pharmaceuticals LtdCommittee For Medicinal Products HumanHead Of Investor Relations Corporate CommunicationsMedicinal ProductsHuman UsePaul ClozelChief Executive OfficerAfrican AmericansNorth AmericaEuropean Economic AreaNorthern Ireland